Skip to content

Oxytocin Levels in Typically Developing Boys

Ontogenic Measurement of Plasma Oxytocin in Typically Developing Boys Using Extracted and Unextracted EIA Methods

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02006381
Enrollment
60
Registered
2013-12-10
Start date
2013-12-31
Completion date
2015-04-30
Last updated
2015-09-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Boys

Keywords

healthy boys, plasma oxytocin, pediatric

Brief summary

Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods.

Detailed description

Measuring basal levels of plasma oxytocin in individuals with typical development across childhood and adolescence using both extracted and unextracted EIA methods. This study is necessary since there is great variability in reported plasma oxytocin in typically developing children from other studies as well as up to 1000 fold variability in such levels using different assay procedures. Further existing studies have not clearly described variation in levels with age. all samples will be taken in the afternoon.

Interventions

None listed

Sponsors

University of North Carolina, Chapel Hill
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
MALE
Age
3 Years to 17 Years
Healthy volunteers
Yes

Inclusion criteria

* Between 3 and 17 years old, inclusive * Consent of parent or guardian.

Exclusion criteria

*

Design outcomes

Primary

MeasureTime frameDescription
Plasma Oxytocin LevelsBaseline oxytocin level at visit 1 (time zero)20 children in each of 3 age cohorts 3-6, 7-12, and 13-17 will participate. Plasma oxytocin levels will be taken at the screening appointment.

Secondary

MeasureTime frameDescription
Inflammatory markersat single time pointC reactive protein and cytokine panel

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026